Literature DB >> 2001185

Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

K Welsh1, N Butters, J Hughes, R Mohs, A Heyman.   

Abstract

The present study was designed to determine which of the memory tasks included in the CERAD (Consortium to Establish a Registry for Alzheimer's Disease) neuropsychological battery best differentiate patients with early Alzheimer's disease from cognitively normal elderly control subjects and also best distinguish between the various levels of severity of the dementia process. A sample of CERAD patients with Alzheimer's disease was stratified by disease severity into those with mild, moderate, or severe dementia and matched with control subjects for sex, age, and education. Using multivariate procedures and cutting scores, the efficacy of each memory measure in distinguishing between these groups and control subjects was determined. The test for delayed recall was found to be the best overall discriminatory measure. The other tests of memory, ie, immediate recall, intrusion errors, and recognition memory, had poor overall discriminability. None of the CERAD memory measures were found to be particularly powerful in staging the severity of dementia. These findings suggest that tests for delayed recall may be particularly useful in the early detection of Alzheimer's disease and should be considered in screening batteries for dementia in community surveys.

Entities:  

Mesh:

Year:  1991        PMID: 2001185     DOI: 10.1001/archneur.1991.00530150046016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  145 in total

1.  fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease.

Authors:  R A Sperling; J F Bates; E F Chua; A J Cocchiarella; D M Rentz; B R Rosen; D L Schacter; M S Albert
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Daily stress magnifies the association between cognitive decline and everyday memory problems: an integration of longitudinal and diary methods.

Authors:  Elizabeth Hahn Rickenbach; David M Almeida; Teresa E Seeman; Margie E Lachman
Journal:  Psychol Aging       Date:  2014-11-03

3.  Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; S C Waring; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

4.  Episodic memory in dementia: Characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases.

Authors:  Eleni Aretouli; Jason Brandt
Journal:  Arch Clin Neuropsychol       Date:  2010-06-08       Impact factor: 2.813

Review 5.  Changes in cognition.

Authors:  Marilyn S Albert
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

6.  Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease.

Authors:  J M Olichney; S K Morris; C Ochoa; D P Salmon; L J Thal; M Kutas; V J Iragui
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 7.  Gonadal hormones and cognitive aging: a midlife perspective.

Authors:  Victor W Henderson
Journal:  Womens Health (Lond)       Date:  2011-01

8.  Confirmatory factor analysis of the ADNI Neuropsychological Battery.

Authors:  Lovingly Quitania Park; Alden L Gross; Donald G McLaren; Judy Pa; Julene K Johnson; Meghan Mitchell; Jennifer J Manly
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

9.  Neuropsychological function in nondemented carriers of presenilin-1 mutations.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; L Fairbanks; F Paz; A Varpetian; H C Maldonado; M A Macias-Islas; J Murrell; B Ghetti; C Kawas
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

10.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.